Antibiotic trial probes Gut's role in MS brain inflammation
NCT ID NCT05539729
Summary
This study aims to understand how the antibiotic vancomycin affects the community of bacteria in the gut and the immune system in people with multiple sclerosis (MS). Researchers will give vancomycin to 12 newly diagnosed, untreated MS patients and track changes in their gut bacteria, blood markers, and brain scans over 6 weeks. The goal is to learn more about the connection between the gut and brain inflammation in MS, not to treat the disease directly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.